arrowTo report an adverse event

arrowFor any other medical emergency or R&D questions


Choose site

Rottapharm | Madaus
is now part of Meda AB


"For more than 50 years, we have been working to find solutions to real problems. In our laboratories, more than 10.000 molecular hits have been synthesized up to date. Thanks to this activity, today we are one of the few Italian companies which can boast the introduction in the international market of several new drugs, nutraceuticals and dermocosmetics representing important milestones in the treatment of specific diseases and for wellbeing maintenance ".


Prof. Luigi Rovati
Rottapharm|Madaus President